OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Infliximab Clearance Predicts Remission in Children with Crohn’s Disease
Aaron Chung, Matthew Carroll, Patrícia de Almeida, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 5, pp. 1995-2005
Closed Access | Times Cited: 6
Aaron Chung, Matthew Carroll, Patrícia de Almeida, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 5, pp. 1995-2005
Closed Access | Times Cited: 6
Showing 6 citing articles:
Baseline Drug Clearance Predicts Outcomes in Children With Inflammatory Bowel Disease Treated With Vedolizumab: Results From the VedoKids Prospective Multicentre Study
Ronen Stein, Dan Turner, Séamus Hussey, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Ronen Stein, Dan Turner, Séamus Hussey, et al.
Alimentary Pharmacology & Therapeutics (2025)
Open Access | Times Cited: 1
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Dahham Alsoud, Dirk Jan A. R. Moes, Zhigang Wang, et al.
Therapeutic Drug Monitoring (2024) Vol. 46, Iss. 3, pp. 291-308
Closed Access | Times Cited: 5
Intestinal tissue levels of anti-TNF alpha, antibodies, and cytokines in paediatric Crohn disease
Vojtěch Dotlačil, Štěpán Coufal, Tereza Lerchová, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Vojtěch Dotlačil, Štěpán Coufal, Tereza Lerchová, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics
Tina Deyhim, Adam S. Cheifetz, Konstantinos Papamichael
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7132-7132
Open Access | Times Cited: 12
Tina Deyhim, Adam S. Cheifetz, Konstantinos Papamichael
Journal of Clinical Medicine (2023) Vol. 12, Iss. 22, pp. 7132-7132
Open Access | Times Cited: 12
Current Role of Monoclonal Antibody Therapy in Pediatric IBD: A Special Focus on Therapeutic Drug Monitoring and Treat-to-Target Strategies
M. Classen, André Hoerning
Children (2023) Vol. 10, Iss. 4, pp. 634-634
Open Access | Times Cited: 3
M. Classen, André Hoerning
Children (2023) Vol. 10, Iss. 4, pp. 634-634
Open Access | Times Cited: 3
Model-informed precision dosing in inflammatory bowel diseases
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
Arno R. Bourgonje, Marla C. Dubinsky, Ron J. Keizer, et al.
Trends in Pharmacological Sciences (2024)
Closed Access
